Search | ARVO Journals

Showing 1 – 20 of 1599

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Letters to the Editor June 2022

Letter to the Editor: Relationship of Choroidal Vasculature and Choriocapillaris Flow With Alterations of Salivary α-Amylase Patterns in Central Serous Chorioretinopathy

PDF

Matteo Menean; Riccardo Sacconi; Giuseppe Querques
TAGS: amylases, central serous chorioretinopathy, fluid flow, vasculature
Invest. Ophthalmol. Vis. Sci.. 2022; 63(6):11. doi: https://doi.org/10.1167/iovs.63.6.11

Letters to the Editor June 2022

Author Response: Relationship of Choroidal Vasculature and Choriocapillaris Flow With Alterations of Salivary α-Amylase Patterns in Central Serous Chorioretinopathy

PDF

Fabio Scarinci; Francesca Romana Patacchioli; Eliana Costanzo; Mariacristina Parravano
TAGS: amylases, central serous chorioretinopathy, fluid flow, vasculature
Invest. Ophthalmol. Vis. Sci.. 2022; 63(6):10. doi: https://doi.org/10.1167/iovs.63.6.10

ARVO Annual Meeting Abstract June 2022

Sex Hormones in Males and Females with Active Central Serous Chorioretinopathy

Joost Brinks; Elon H.C. van Dijk; Roula Tsonaka; Onno C. Meijer; Camiel J F Boon

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1180 – A0034. doi:

ARVO Annual Meeting Abstract June 2022

Transscleral Optical Imaging (TOI) in Central Serous Chorioretinopathy – A novel imaging tool in retinal pigment epithelium visualization

Vishal Govindahari; Laura Kowalczuk; Antonio Iskandar; Zuzana Misutkova; Aurélia Gryczka; Aurélie Navarro; Fanny Jeunet; Irmela Mantel; Christophe Moser; Francine F Behar-Cohen

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1011 – F0258. doi:

ARVO Annual Meeting Abstract June 2022

Late hyperfluorescent plaque in type 1 choroidal neovascularization in age-related macular degeneration and central serous chorioretinopathy

Marta Zola; Elodie Bousquet; Catherine Favard; Anthony Gigon; Irmela Mantel; Francine F Behar-Cohen

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2667. doi:

ARVO Annual Meeting Abstract June 2022

Seven-year clinical outcomes of Central Serous Chorioretinopathy according to age

Seung-Young Yu; Junwoo Lee; Kiyoung Kim; Eung Suk Kim

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3353 – F0162. doi:

ARVO Annual Meeting Abstract June 2022

Central serous chorioretinopathy: a restrospective appraisal of choroidal neovascularization types 1 and 2 in nonconsecutive subjects

Anna Paula Amaral Nassaralla; Miguel Hage Amaro; Arthur Nassaralla; Jorge Mitre; Teruo Aihara; Luiz Lima; Joao J Nassaralla

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3809 – F0230. doi:

ARVO Annual Meeting Abstract June 2022

Clinical outcome of central serous chorioretinopathy with or without choroidal neovascularization

AYA KAMIMURA; Akiko Miki; Maya Kishimoto; Wataru Matsumiya; Hisanori Imai; Sentaro Kusuhara; Makoto Nakamura

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3807 – F0228. doi:

ARVO Annual Meeting Abstract June 2022

Subthreshold Photocoagulation Treatment of Recurrent Central Serous Chorioretinopathy with Pachychoroid Pigment Epitheliopathy

Zhaoxia Zhang; Bin Sun; Juan Xie; Guangping Hou

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3806 – F0227. doi:

ARVO Annual Meeting Abstract June 2022

Comparison of long-term efficacy between intravitreal anti-VEGF and photodynamic therapy for the treatment of central serous chorioretinopathy with flat irregular pigment epithelium detachment

Jimin Park; Joon Hyung Yeo; Yoon Jeon Kim; Junyeop Lee; Joo Yong Lee; June-Gone Kim; Young Hee Yoon

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3767 – F0188. doi:

ARVO Annual Meeting Abstract June 2022

Spontaneous resolution of subretinal fluid in chronic central serous chorioretinopathy: the Fuji sign

Camiel J F Boon; Helena Margaret Anthonia Feenstra; Jonathan Hensman; Theodora Gkika; Carel C B Hoyng; Roselie M.H. Diederen; Reinier O. Schlingemann; Susan M. Downes; Elon H.C. van Dijk

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3763 – F0184. doi:

ARVO Annual Meeting Abstract June 2022

Association of fundus autofluorescence changes and pachydrusen in central serous chorioretinopathy and polypoidal choroidal vasculopathy

Timothy Y Y Lai; Ziqi Tang; Adrian C W Lai; Ricky Y K Lai; Carol Y. Cheung

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3753 – F0174. doi:

ARVO Annual Meeting Abstract June 2022

Efficacy and Safety of Subthreshold laser Treatment for Chronic Central Serous Chorioretinopathy

Walid Raslan; Saad Younis

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3795 – F0216. doi:

ARVO Annual Meeting Abstract June 2022

Central Serous Chorioretinopathy associated with Ocular Tuberculosis

Jila Noorikolouri; Christian Leal

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3217 – A0443. doi:

ARVO Annual Meeting Abstract June 2022

Newly Diagnosed Central Serous Chorioretinopathy: Demographics and Epidemiology from the IRIS ® Registry (Intelligent Research in Sight)

Kapil Mishra; Arthur Brant; Suzann Pershing; Ashton Tristan Perlroth; Henry Bair; Christine Xu; Diana V Do

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2541 – A0110. doi:

ARVO Annual Meeting Abstract June 2022

Longitudinal structural and functional changes in Central Serous Chorioretinopathy: A ten-year multimodal imaging-based study

Niroj Kumar Sahoo; Joshua Ong; Amrish Selvam; Dmitri Maltsev; Riccardo Sacconi; Ramesh Venkatesh; Nikitha Reddy; Shivam Madan; Luiz Lima; Varsha Pramil; Dr Giridhar; Gerardo Ledesma-Gil; Nadia K Waheed; Enrico Borrelli; Giuseppe QUERQUES; Jay Chhablani

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1003 – F0250. doi:

ARVO Annual Meeting Abstract June 2022

High positive predictive value of fluorescein angiography contiguous perinerve retinal vascular leakage pattern for birdshot chorioretinopathy

Ashley Li; Lucia Sobrin

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3921 – A0464. doi:

ARVO Annual Meeting Abstract June 2022

Transcriptome analysis of the human choroid qualifies endothelial androgen responses as a disease driver for Central Serous Chorioretinopathy

Steffen Emil Künzel; Sandrine Helene Künzel; Dominik Pascal Frentzel; Dominika Pohlmann; Lynn Zur Bonsen; Oliver Zeitz; Antonia M. Joussen; Alexandre Dubrac

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):39. doi:

ARVO Annual Meeting Abstract June 2022

Safety and efficacy of fovea-involving half-dose photodynamic therapy for chronic central serous chorioretinopathy

Helena Margaret Anthonia Feenstra; Roselie M.H. Diederen; Martine J.C.M. Lamme; Sascha Fauser; Susan M. Downes; Reinier O. Schlingemann; Carel C B Hoyng; Elon H.C. van Dijk; Camiel J F Boon

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):37. doi:

Articles May 2022

Electrophysiological Assessment in Birdshot Chorioretinopathy: Flicker Electroretinograms Recorded With a Handheld Device

PDF

Anna M. Waldie; Angharad E. Hobby; Isabelle Chow; Elisa E. Cornish; Mathura Indusegaran; Aleksandra Pekacka; Phuc Nguyen; Clare Fraser; Alison M. Binns; Miles R. Stanford; Christopher J. Hammond; Peter J. McCluskey; John R. Grigg; Omar A. Mahroo
TAGS: electroretinography, mobile devices, photopsia, vitiliginous chorioretinitis, electrophysiology
Trans. Vis. Sci. Tech.. 2022; 11(5):23. doi: https://doi.org/10.1167/tvst.11.5.23

1 2 3 4 5

Next 20 Results »

Search Results for chorioretinopathy

NARROW

Content Type

Journal

Article Type

Topics

Tags

Filters

Specify Date Range

Letter to the Editor: Relationship of Choroidal Vasculature and Choriocapillaris Flow With Alterations of Salivary α-Amylase Patterns in Central Serous Chorioretinopathy

Author Response: Relationship of Choroidal Vasculature and Choriocapillaris Flow With Alterations of Salivary α-Amylase Patterns in Central Serous Chorioretinopathy

Sex Hormones in Males and Females with Active Central Serous Chorioretinopathy

Transscleral Optical Imaging (TOI) in Central Serous Chorioretinopathy – A novel imaging tool in retinal pigment epithelium visualization

Late hyperfluorescent plaque in type 1 choroidal neovascularization in age-related macular degeneration and central serous chorioretinopathy

Seven-year clinical outcomes of Central Serous Chorioretinopathy according to age

Central serous chorioretinopathy: a restrospective appraisal of choroidal neovascularization types 1 and 2 in nonconsecutive subjects

Clinical outcome of central serous chorioretinopathy with or without choroidal neovascularization

Subthreshold Photocoagulation Treatment of Recurrent Central Serous Chorioretinopathy with Pachychoroid Pigment Epitheliopathy

Comparison of long-term efficacy between intravitreal anti-VEGF and photodynamic therapy for the treatment of central serous chorioretinopathy with flat irregular pigment epithelium detachment

Spontaneous resolution of subretinal fluid in chronic central serous chorioretinopathy: the Fuji sign

Association of fundus autofluorescence changes and pachydrusen in central serous chorioretinopathy and polypoidal choroidal vasculopathy

Efficacy and Safety of Subthreshold laser Treatment for Chronic Central Serous Chorioretinopathy

Central Serous Chorioretinopathy associated with Ocular Tuberculosis

Newly Diagnosed Central Serous Chorioretinopathy: Demographics and Epidemiology from the IRIS ® Registry (Intelligent Research in Sight)

Longitudinal structural and functional changes in Central Serous Chorioretinopathy: A ten-year multimodal imaging-based study

High positive predictive value of fluorescein angiography contiguous perinerve retinal vascular leakage pattern for birdshot chorioretinopathy

Transcriptome analysis of the human choroid qualifies endothelial androgen responses as a disease driver for Central Serous Chorioretinopathy

Safety and efficacy of fovea-involving half-dose photodynamic therapy for chronic central serous chorioretinopathy

Electrophysiological Assessment in Birdshot Chorioretinopathy: Flicker Electroretinograms Recorded With a Handheld Device

Search Results for chorioretinopathy

To View More...

You must be signed into an individual account to use this feature.